- Merck & Co. (Rahway, NJ)
- …experienced talented scientist to join the-Quantitative Pharmacology and Pharmacometrics --Immune/ Oncology -(QP2-IO)-team in the role of-Senior ... has oversight over drug development aspects related to clinical pharmacology and pharmacometrics of oncology drugs from post-Preclinical Candidate (PCC) to… more
- Daiichi Sankyo, Inc. (Basking Ridge, NJ)
- …Description Join a Legacy of Innovation 110 Years and Counting!Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies ... of promising new medicines to help people. Under the Group 's 2025 Vision to become a "Global Pharma Innovator...become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel… more
- Pfizer (New York, NY)
- …of drugs and expand the application of model-informed drug development (MIDD) approaches within oncology and across our portfolio. You will lead a team of ... RESPONSIBILITIES** + Provide scientific, technical, and strategic leadership of the pharmacometrics function within oncology , and other therapeutic areas as… more
- Merck (Rahway, NJ)
- …seeking an experienced talented scientist to join the **Quantitative Pharmacology and Pharmacometrics -** **Immune/ Oncology ** **(QP2-IO)** team in the role of ... over drug development aspects related to clinical pharmacology and pharmacometrics of oncology drugs from post-Preclinical Candidate...go/no-go decisions + Being or supporting the QP2-I/O Function Lead on oncology development teams. + Data… more
- Daiichi Sankyo Inc. (Basking Ridge, NJ)
- Join a Legacy of Innovation 110 Years and Counting! Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve ... of promising new medicines to help people. Under the Group 's 2025 Vision to become a "Global Pharma Innovator...become a "Global Pharma Innovator with Competitive Advantage in Oncology ," Daiichi Sankyo is primarily focused on providing novel… more
